First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy

被引:10
|
作者
Loconsole, Daniela [1 ]
De Robertis, Anna Lisa [1 ]
Mallamaci, Rosanna [2 ]
Sallustio, Anna [1 ]
Morea, Anna [1 ]
Prato, Rosa [3 ]
Quarto, Michele [1 ]
Martinelli, Domenico [3 ]
Chironna, Maria [1 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Hyg Sect, Piazza G Cesare 11, I-70124 Bari, Italy
[2] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70124 Bari, Italy
[3] Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy
关键词
D O I
10.1155/2019/7168949
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP). This cross-sectional study aimed to determine the prevalence of macrolide-resistant M. pneumoniae strains in a convenience series of 234 adult hospitalised and nonhospitalised subjects with a diagnosis of CAP in January 2013 to April 2015 in South Italy. Methods. Respiratory samples were subjected to real-time PCR. In M. pneumoniae-positive samples, domain V of 23S rRNA was sequenced to detect resistance-conferring point mutations. P1 major adhesion protein typing and multiple loci variable-number tandem repeat analysis (MLVA) were also performed. Results. Of the 234 samples, 15 (6.4%) were positive for M. pneumoniae. Three of these had a macrolide-resistant genotype: two and one had A2063G and A2064G mutations, respectively. Fourteen of the 15 strains were subtyped: half had subtype 1 and half had subtype 2. Eight strains underwent MLVA profiling: one each had the J, A, and Z type. The remainder was unclassifiable. Conclusions. This novel discovery of macrolide-resistant M. pneumoniae strains in adults with CAP in Italy suggests that there may be increasing circulation of these strains in the population. To facilitate rapid optimization of the antibiotic strategy in Italy, macrolide resistance should be monitored by a surveillance system that is based on molecular methods.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] RAPID DEFERVESCENCE AFTER DOXYCYCLINE TREATMENT OF MACROLIDE-RESISTANT MYCOPLASMA PNEUMONIAE-ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
    Lung, David Christopher
    Tong, Eric Kam
    Lam, David Shu Yan
    Que, Tak Lun
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (12) : 1396 - 1399
  • [22] Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia Is There Still a Role for Macrolide Therapy?
    Niederman, Michael S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1216 - 1217
  • [23] The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
    Dai, Fang-fang
    Liu, Feng-qin
    Chen, Xing
    Yang, Juan
    Wang, Ke
    Guo, Chun-yan
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 705 - 710
  • [24] Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure
    Cheong, Kai-Ning
    Chiu, Susan S.
    Chan, Betsy Wai-Ka
    To, Kelvin Kai-Wang
    Chan, Eunice Lai-Yin
    Ho, Pak-Leung
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 127 - 130
  • [25] Macrolide-Resistant Mycoplasma pneumoniae in Adults in Zhejiang, China
    Zhou, Zibo
    Li, Xiangzhi
    Chen, Xiaojian
    Luo, Fangjun
    Pan, Changwang
    Zheng, Xiaoping
    Tana, Feng
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1048 - 1051
  • [26] Efficacy of Azithromycin in the Treatment of Community-acquired Pneumonia, Including Patients with Macrolide-Resistant Streptococcus pneumoniae Infection
    Yanagihara, Katsunori
    Izumikawa, Koichi
    Higa, Futoshi
    Tateyama, Masao
    Tokimatsu, Issei
    Hiramatsu, Kazufumi
    Fujita, Jiro
    Kadota, Jun-ichi
    Kohno, Shigeru
    [J]. INTERNAL MEDICINE, 2009, 48 (07) : 527 - 535
  • [27] Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study
    Yin, Yu-Dong
    Wang, Rui
    Zhuo, Chao
    Wang, Hui
    Wang, Ming-Gui
    Xie, Can-Mao
    She, Dan-Yang
    Yuan, Xin
    Wang, Ren-Tao
    Cao, Bin
    Liu, You-Ning
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3774 - 3781
  • [28] Macrolide-resistant Streptococcus pneumoniae in community-acquired pneumonia:: Clinical and microbiological outcomes for patients treated with levofloxacin
    Kahn, JB
    Wiesinger, BA
    Xiang, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S24 - S33
  • [29] First Report of Macrolide Resistance in a Mycoplasma pneumoniae Isolate Causing Community-Acquired Pneumonia in Spain
    de Dios Caballero, Juan
    del Campo, Rosa
    del Carmen Mafe, Maria
    Galvez, Maria
    Rodriguez-Dominguez, Mario
    Canton, Rafael
    Antonia Meseguer, Maria
    Manuel Hermida, Jose
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1265 - 1266
  • [30] Mycoplasma pneumoniae and community-acquired pneumonia
    Dey, AB
    Chaudhry, R
    Kumar, P
    Nisar, N
    Nagarkar, KM
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2000, 13 (02): : 66 - 70